Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01248819Phase 3Completed
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Fondazione IRCCS San Gerardo dei Tintori. Primary endpoint: Postoperative Pain at 48 hours. Started Apr 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01248819.